PDSB
PDS Biotechnology Corp
1.10$
+1.9%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +5,233.4% | +95.2% | +686.6% | -17.3% | -16.5% | -60.9% | -60.0% | +113.2% | +117.5% | +14.6% | -22.9% | -23.6% | -32.8% | |
| – | +5,687.1% | +81.0% | +750.1% | -18.2% | -17.0% | -60.0% | -59.4% | +109.7% | +120.3% | +14.4% | -22.8% | -23.7% | -37.3% | |
| – | +5,475.8% | +74.7% | +848.3% | -18.3% | -17.2% | -60.7% | -64.9% | +137.1% | +126.2% | +13.1% | -23.4% | -26.3% | -35.9% | |
| – | +5,475.8% | +74.7% | +848.3% | -18.3% | -17.2% | -60.7% | -64.9% | +137.1% | +126.2% | +13.1% | -23.4% | -26.3% | -35.9% | |
| – | – | – | – | – | -71.1% | – | – | – | – | – | – | – | – | |
| – | – | – | – | -97.4% | -29.1% | -43.1% | -28.7% | +2,527.7% | -35.3% | +47.5% | – | – | – | |
| – | – | – | – | – | -9.8% | -10.9% | – | – | – | – | – | – | – | |
| – | +578.8% | +86.4% | -74.1% | +86.3% | +39.8% | -78.9% | -56.2% | +34.6% | +6.0% | +727.7% | +0.8% | -20.8% | -19.4% | |
| – | -49.2% | +117.7% | +120.6% | -22.2% | +92.5% | -50.4% | -56.2% | +17.1% | +14.8% | +161.5% | +38.8% | +25.4% | -44.5% | |
| – | – | – | -218.0% | – | – | – | – | – | +115.9% | +11.2% | +1,365.9% | +197.5% | -58.9% | |
| – | – | +88.2% | +26.3% | +34.3% | +25.9% | -90.9% | +199.8% | +18.2% | -7.5% | -6.9% | +472.7% | -75.9% | +112.2% | |
| – | – | – | – | +394.3% | +16.2% | -99.8% | – | – | – | – | -15.3% | -52.8% | +27.5% | |
| – | – | – | – | -27.1% | -30.1% | -52.2% | -60.8% | +131.9% | +133.0% | -30.4% | -40.6% | -27.3% | -51.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +85.7% | +2.9% | +5.3% | +162.3% | +22.1% | +244.0% | +52.9% | +11.7% | +8.2% | +17.8% | +27.2% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.